MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-20-2026
Abbott Laboratories Cash Conversion Cycle 2011-2026 | ABT
Annual Cash Conversion Cycle Abbott Laboratories
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 101 | 100 | 97.2 | 75.2 | 72.5 | 88.3 | 91.4 | 85.4 | 105 | 108 | 124 | 127 | 127 | 118 | 109 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 127 | 72.5 | 102 |
Quarterly Cash Conversion Cycle Abbott Laboratories
| 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 110 | 116 | 113 | 112 | 115 | 110 | 108 | 100 | - | 43.9 | 37.7 | 67.8 | - | 79.8 | 79.8 | 79.3 | - | 90.6 | 110 | 99.5 | 59.5 | 90.2 | 91.7 | 91.4 | 60.9 | 85.4 | 83.7 | 94.5 | 63.1 | 108 | 106 | 61.2 | 55.6 | 55.9 | 55.6 | 62.3 | 60.1 | 60.6 | 60.3 | 65.3 | 61.1 | 64.4 | 64.7 | 72.7 | 71.7 | 75.7 | 73.7 | 109 | 123 | 132 | 131 | 132 | 67.6 | 71.4 | 72.9 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 132 | 37.7 | 84 |
Cash Conversion Cycle of other stocks in the Medical devices industry
| Issuer | Cash Conversion Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
GenMark Diagnostics, Inc.
GNMK
|
104 | - | - | $ 1.77 B |  USA |
 |
Acutus Medical
AFIB
|
761 | - | -26.83 % | $ 2.62 M | USA |
 |
AdaptHealth Corp.
AHCO
|
20.1 | $ 12.0 | -0.58 % | $ 1.62 B | USA |
 |
Allied Healthcare Products
AHPI
|
271 | - | 3.58 % | $ 2.21 M | USA |
 |
Lianluo Smart Limited
LLIT
|
94.1 | - | 24.59 % | $ 44.8 M |  China |
 |
ClearPoint Neuro
CLPT
|
217 | $ 9.15 | -2.51 % | $ 259 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
174 | - | -5.86 % | $ 30.6 M | USA |
 |
Bruker Corporation
BRKR
|
227 | $ 36.35 | -1.05 % | $ 5.42 K | USA |
 |
Apollo Endosurgery
APEN
|
156 | - | - | $ 475 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
714 | $ 15.71 | -1.44 % | $ 369 M | USA |
 |
EDAP TMS S.A.
EDAP
|
136 | $ 3.4 | -1.73 % | $ 127 M |  France |
 |
CryoLife, Inc.
CRY
|
183 | - | -4.14 % | $ 702 M | USA |
 |
Avinger
AVGR
|
335 | - | -20.74 % | $ 369 K | USA |
 |
Align Technology
ALGN
|
137 | $ 168.12 | -2.18 % | $ 12.6 B | USA |
 |
AxoGen
AXGN
|
245 | $ 31.05 | -4.87 % | $ 1.43 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
299 | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
-81.2 | - | 1.37 % | $ 20.5 M | USA |
 |
Soliton, Inc.
SOLY
|
-67.9 | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
9.86 | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
-227 | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
28.8 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
81.2 | - | - | $ 111 M |  Canada |
 |
Butterfly Network
BFLY
|
815 | $ 4.01 | -2.91 % | $ 849 M | USA |
 |
Intersect ENT, Inc.
XENT
|
45.4 | - | - | $ 955 M | USA |
 |
Cytosorbents Corporation
CTSO
|
104 | $ 0.61 | 3.37 % | $ 38 M | USA |
 |
TELA Bio
TELA
|
185 | $ 0.69 | 9.81 % | $ 32.4 M | USA |
 |
BIOLASE
BIOL
|
129 | - | -13.19 % | $ 166 K | USA |
 |
Delcath Systems
DCTH
|
258 | $ 9.65 | -0.52 % | $ 346 M | USA |
 |
FONAR Corporation
FONR
|
234 | $ 18.58 | -0.11 % | $ 122 M | USA |
 |
BioSig Technologies
BSGM
|
607 | - | 37.08 % | $ 85.7 M | USA |
 |
Boston Scientific Corporation
BSX
|
107 | $ 61.35 | -1.93 % | $ 90.8 B | USA |
 |
Alphatec Holdings
ATEC
|
240 | $ 11.1 | 1.19 % | $ 1.67 B | USA |
 |
CONMED Corporation
CNMD
|
212 | $ 34.34 | 0.81 % | $ 1.07 B | USA |
 |
Globus Medical
GMED
|
314 | $ 90.53 | 2.15 % | $ 12.2 B | USA |
 |
Edwards Lifesciences Corporation
EW
|
283 | $ 80.81 | -0.42 % | $ 47.3 B | USA |
 |
Helius Medical Technologies
HSDT
|
18.2 | $ 1.76 | -7.37 % | $ 1.07 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
222 | $ 9.31 | - | $ 717 M | USA |
 |
Inspire Medical Systems
INSP
|
248 | $ 54.8 | 1.25 % | $ 1.61 B | USA |
 |
IRIDEX Corporation
IRIX
|
105 | $ 1.0 | 0.34 % | $ 16.9 M | USA |
 |
Integer Holdings Corporation
ITGR
|
96.8 | $ 85.37 | -0.29 % | $ 2.97 B | USA |
 |
Conformis
CFMS
|
165 | - | - | $ 16.4 M | USA |
 |
LENSAR
LNSR
|
85.4 | $ 5.84 | -0.85 % | $ 69.8 M | USA |
 |
Cardiovascular Systems
CSII
|
172 | - | 0.15 % | $ 844 M | USA |
 |
Cutera
CUTR
|
404 | - | -10.19 % | $ 1.99 M | USA |
 |
Medtronic PLC
MDT
|
160 | $ 86.48 | 0.22 % | $ 111 B | USA |
 |
Dynatronics Corporation
DYNT
|
80.5 | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
32.7 | - | - | $ 10.2 M | USA |
 |
Myomo
MYO
|
82.3 | $ 0.67 | -4.29 % | $ 28 M | USA |
 |
Second Sight Medical Products
EYES
|
-29.6 | - | -0.97 % | $ 54.4 M | USA |